The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation
Open accessAbstract
Axonal degeneration contributes to clinical disability in the acquired demyelinating disease multiple sclerosis. Axonal degeneration occurs during acute attacks, associated with inflammation, and during the chronic progressive phase of the disease in which inflammation is not prominent. To explore the importance of interactions between oligodendrocytes and axons in the CNS, we analysed the brains of rodents and humans with a null mutation in the gene encoding the major CNS myelin protein, proteolipid protein (PLP1, previously PLP). Histological analyses of the CNS of Plp1 null mice and of autopsy material from patients with null PLP1 mutations were performed to evaluate axonal and myelin integrity. In vivo proton magnetic resonance spectroscopy (MRS) of PLP1 null patients was conducted to measure levels of N-acetyl aspartate (NAA), a marker of axonal integrity. Length-dependent axonal degeneration without demyelination was identified in the CNS of Plp1 null mice. Proton MRS of PLP1-deficient patients showed reduced NAA levels, consistent with axonal loss. Analysis of patients' brain tissue also demonstrated a length-dependent pattern of axonal loss without significant demyelination. Therefore, axonal degeneration occurs in humans as well as mice lacking the major myelin protein PLP1. This degeneration is length-dependent, similar to that found in the PNS of patients with the inherited demyelinating neuropathy, CMT1A, but is not associated with significant demyelination. Disruption of PLP1-mediated axonal--glial interactions thus probably causes this axonal degeneration. A similar mechanism may be responsible for axonal degeneration and clinical disability that occur in patients with multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Estimation of metabolite concentrations from localized in vivo proton NMR spectra
Provencher, S. W. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910300604 · Cited by 3,655
American Journal of Neuroradiology
(2020) · American Journal of Neuroradiology · doi:10.3174/ajnr · Cited by 2,453
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889
Self-citationde Waegh, S. M., Lee, V. M.-Y., & Brady, S. T. (1992) · Cell · doi:10.1016/0092-8674(92)90183-d · Cited by 742
Assembly of CNS Myelin in the Absence of Proteolipid Protein
Klugmann, M., Schwab, M. H., Pühlhofer, A., Schneider, A., Zimmermann, F., Griffiths, I. R., & Nave, K.-A. (1997) · Neuron · doi:10.1016/s0896-6273(01)80046-5 · Cited by 471
Self-citationRegional metabolite concentrations in human brain as determined by quantitative localized proton MRS
Pouwels, P. J. W., & Frahm, J. (1998) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910390110 · Cited by 465
Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A
Krajewski, K. M. (2000) · Brain · doi:10.1093/brain/123.7.1516 · Cited by 414
Multisection proton MR spectroscopic imaging of the brain.
Duyn, J. H., Gillen, J., Sobering, G., van Zijl, P. C., & Moonen, C. T. (1993) · Radiology · doi:10.1148/radiology.188.1.8511313 · Cited by 356
Pouwels, P. J. W., Brockmann, K., Kruse, B., Wilken, B., Wick, M., Hanefeld, F., & Frahm, J. (1999) · Pediatric Research · doi:10.1203/00006450-199910000-00019 · Cited by 309
Quantitative proton MR spectroscopic imaging of the human brain
Soher, B. J., van Zijl, P. C. M., Duyn, J. H., & Barker, P. B. (1996) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910350313 · Cited by 271
Sun, J., Olsson, T., Wang, W., Xiao, B., Kostulas, V., Fredrikson, S., Ekre, H., & Link, H. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210620 · Cited by 257
De Jonghe, P., Timmerman, V., Ceuterick, C., Nelis, E., De Vriendt, E., Löfgren, A., Vercruyssen, A., Verellen, C., Van Maldergem, L., Martin, J.-J., et al. (1999) · Brain · doi:10.1093/brain/122.2.281 · Cited by 224
Formation of Compact Myelin Is Required for Maturation of the Axonal Cytoskeleton
Brady, S. T., Witt, A. S., Kirkpatrick, L. L., de Waegh, S. M., Readhead, C., Tu, P.-H., & Lee, V. M.-Y. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07278.1999 · Cited by 197
ZEMAN, W., DEMYER, W., & FALLS, H. F. (1964) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-196404000-00008 · Cited by 179
Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene
Marrosu, M. G., Vaccargiu, S., Marrosu, G., Vannelli, A., Cianchetti, C., & Muntoni, F. (1998) · Neurology · doi:10.1212/wnl.50.5.1397 · Cited by 174
X-LINKED DOMINANT HEREDITARY MOTOR AND SENSORY NEUROPATHY
Hahn, A. F., Brown, W. F., Koopman, W. J., & Feasby, T. E. (1990) · Brain · doi:10.1093/brain/113.5.1511 · Cited by 155
Proteolipid Protein Is Necessary in Peripheral as Well as Central Myelin
Garbern, J. Y., Cambi, F., Tang, X.-M., Sima, A. A. F., Vallat, J. M., Bosch, E. P., Lewis, R. A., Shy, M. E., Sohi, J., Kraft, G. H., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80360-8 · Cited by 154
Self-citationLate-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene
Anderson, T. J., Schneider, A., Barrie, J. A., Klugmann, M., McCulloch, M. C., Kirkham, D., Kyriakides, E., Nave, K., & Griffiths, I. R. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980518)394:4<506::aid-cne8>3.0.co;2-5 · Cited by 132
Self-citationChapon, F., Latour, P., Diraison, P., Schaeffer, S., & Vandenberghe, A. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.6.779 · Cited by 125
The proteolipid protein gene and myelin disorders in man and animal models
Yool, D. A., Edgar, J. M., Montague, P., & Malcolm, S. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.987 · Cited by 102
Self-citationNeuropathology and Genetics of Pelizaeus‐Merzbacher Disease
SEITELBERGER, F. (1995) · Brain Pathology · doi:10.1111/j.1750-3639.1995.tb00603.x · Cited by 100
Axonal Injury or Loss in the Internal Capsule and Motor Impairment in Multiple Sclerosis
Lee, M. A., Blamire, A. M., Pendlebury, S. T., Ho, K.-H., Mills, K. R., Styles, P., Palace, J. A., & Matthews, P. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.65 · Cited by 99
Genotype/Phenotype Correlations in X‐Linked Dominant Charcot‐Marie‐Tooth Disease
Hahn, A. F., Bolton, C. F., White, C. M., Brown, W. F., Tuuha, S. E., Tan, C. C., & Ainsworth, P. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08598.x · Cited by 92
Frei, R., Mötzing, S., Kinkelin, I., Schachner, M., Koltzenburg, M., & Martini, R. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-14-06058.1999 · Cited by 88
Myelin proteolipid protein induces demyelinating disease in mice
Trotter, J. L., Clark, H. B., Collins, K. G., Wegeschiede, C. L., & Scarpellini, J. D. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90271-1 · Cited by 81
Bongarzone, E. R., Campagnoni, C. W., Kampf, K., Jacobs, E. C., Handley, V., Schonmann, V., & Campagnoni, A. T. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08349.1999 · Cited by 78
Stefano, N. D., Matthews, P. M., Narayanan, S., Francis, G., Antel, J. P., & Arnold, D. L. (1997) · Neurology · doi:10.1212/wnl.49.4.1138 · Cited by 77
Pelfrey, C. M., Trotter, J. L., Tranquill, L. R., & McFarland, H. F. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90231-m · Cited by 76
Correale, J. D., McMillan, M., McCarthy, K. A., Le, T. D., & Weiner, L. P. (1995) · Neurology · doi:10.1212/wnl.45.7.1370 · Cited by 74
Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons
Yool, D. A., Klugmann, M., McLaughlin, M., Vouyiouklis, D. A., Dimou, L., Barrie, J. A., McCulloch, M. C., Nave, K., & Griffiths, I. R. (2001) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20010115)63:2<151::aid-jnr1007>3.0.co;2-y · Cited by 67
Self-citationEndoh, M., Tabira, T., Kunishita, T., Sakai, K., Yamamura, T., & Taketomi, T. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.12.3832 · Cited by 66
Trotter, J. L., Hickey, W. F., van der Veen, R. C., & Sulze, L. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90034-5 · Cited by 64
Sistermans, E. A., de Wijs, S., de Coo, I. F. M., van Oost, B. A., Smit, L. M. E., & Menko, F. H. (1996) · Human Genetics · doi:10.1007/bf02185767 · Cited by 61
Self-citationAxonal degeneration is an early pathological feature in autoimmune‐mediated demyelination in mice
Onuki, M., Ayers, M. M., Bernard, C. C. A., & Orian, J. M. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1057 · Cited by 52
Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations
Bonavita, S., Schiffmann, R., Moore, D. F., Frei, K. P., Choi, B., Patronas, N. J., Virta, A., Boespflug‐Tanguy, O., & Tedeschi, G. (2001) · Neurology · doi:10.1212/wnl.56.6.785 · Cited by 43
Pelfrey, C. M., Trotter, J. L., Tranquill, L. R., & McFarland, H. F. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90025-6 · Cited by 36
Localization in Clinical Neurology, 3rd Ed.
Averbuch‐Heller, L. (1997) · Neurology · doi:10.1212/wnl.49.2.644-c · Cited by 27
Cited by
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Oligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder
Tkachev, D., Mimmack, M. L., Ryan, M. M., Wayland, M., Freeman, T., Jones, P. B., Starkey, M., Webster, M. J., Yolken, R. H., & Bahn, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14289-4 · Cited by 933
Metadata
- Authors
- Garbern, J. Y., Yool, D. A., Moore, G. J., Wilds, I. B., Faulk, M. W., Klugmann, M., Nave, K.-A., Sistermans, E. A., van der Knaap, M. S., Bird, T. D., Shy, M. E., Kamholz, J. A., & Griffiths, I. R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-05-01
- Volume
- 125
- Issue
- 3
- Pages
- 551-561
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2119961485
- Cited by
- 298
- References
- 40
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.